Patent 12077789 was granted and assigned to Illumina on September, 2024 by the United States Patent and Trademark Office.
Presented herein are altered polymerase enzymes for improved incorporation of nucleotides and nucleotide analogues, in particular altered polymerases that maintain low pre-phasing rates when using ambiently stored polymerases, as well as methods and kits using the same.